These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 17128123)

  • 1. [Speech therapy guidelines in patients with amyotrophic lateral sclerosis].
    Lévêque N
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S269-4S272. PubMed ID: 17128123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What are management practices for speech therapy in amyotrophic lateral sclerosis?].
    Sancho PO; Boisson D
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S273-4S274. PubMed ID: 17128124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acoustic parameters of voice and speech in a case of bulbar amyotrophic lateral sclerosis].
    Crevier-Buchman L; Laccourreye O; Meininger V; Salachas F; Brihaye S; Brasnu D
    Ann Otolaryngol Chir Cervicofac; 1995; 112(4):169-73. PubMed ID: 7574245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysarthria in amyotrophic lateral sclerosis: A review.
    Tomik B; Guiloff RJ
    Amyotroph Lateral Scler; 2010; 11(1-2):4-15. PubMed ID: 20184513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive speech deterioration and dysphagia in amyotrophic lateral sclerosis: case report.
    Dworkin JP; Hartman DE
    Arch Phys Med Rehabil; 1979 Sep; 60(9):423-5. PubMed ID: 496610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis.
    Kühnlein P; Gdynia HJ; Sperfeld AD; Lindner-Pfleghar B; Ludolph AC; Prosiegel M; Riecker A
    Nat Clin Pract Neurol; 2008 Jul; 4(7):366-74. PubMed ID: 18560390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The otolaryngologist's role in the diagnosis and treatment of amyotrophic lateral sclerosis.
    McGuirt WF; Blalock D
    Laryngoscope; 1980 Sep; 90(9):1496-501. PubMed ID: 7401852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of voice and speech during bulbar and pseudo-bulbar syndromes].
    Chevrie-Muller C; Dordain M; Gremy F
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1968 Mar; 17(3):225-32. PubMed ID: 4246935
    [No Abstract]   [Full Text] [Related]  

  • 9. Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis.
    Pattee GL; Plowman EK; Focht Garand KL; Costello J; Brooks BR; Berry JD; Smith RA; Atassi N; Chapin JL; Yunusova Y; McIlduff CE; Young E; Macklin EA; Locatelli ER; Silani V; Heitzman D; Wymer J; Goutman SA; Gelinas DF; Perry B; Nalipinski P; Stipancic K; O'Brien M; Sullivan SL; Pioro EP; Gargiulo G; Green JR;
    Muscle Nerve; 2019 May; 59(5):531-536. PubMed ID: 30620104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems of communication in nervous system diseases and their management--communication in patients with amyotrophic lateral sclerosis].
    Beppu H; Furuta K
    Kango Gijutsu; 1976 Feb; 22(3):99-106. PubMed ID: 1044771
    [No Abstract]   [Full Text] [Related]  

  • 11. Speech deterioration in amyotrophic lateral sclerosis (ALS) after manifestation of bulbar symptoms.
    Makkonen T; Ruottinen H; Puhto R; Helminen M; Palmio J
    Int J Lang Commun Disord; 2018 Mar; 53(2):385-392. PubMed ID: 29159848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
    Pinto S; Pinto A; De Carvalho M
    Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis: comprehensive management.
    DeLisa JA; Mikulic MA; Miller RM; Melnick RR
    Am Fam Physician; 1979 Mar; 19(3):137-42. PubMed ID: 425866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A different form of "pure agraphia": syntactic writing errors in a patients with motor speech and movement disorders.
    Ferguson JH; Boller F
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):79-86. PubMed ID: 616562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amyotrophic lateral sclerosis that begins with voice and deglution alterations].
    Faubel Serra M; Pardo Mateu L; Perez Climent F; Llavero Segovia MT; Cano Cuenca B; Grau Alario E; Gimenez Vaillo F; Canals Ruiz P
    An Otorrinolaringol Ibero Am; 2006; 33(3):273-80. PubMed ID: 16881554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of augmentative communication devices in the medical management of ALS.
    Brownlee A; Palovcak M
    NeuroRehabilitation; 2007; 22(6):445-50. PubMed ID: 18198430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive care of amyotrophic lateral sclerosis patients: a care model.
    Güell MR; Antón A; Rojas-García R; Puy C; Pradas J;
    Arch Bronconeumol; 2013 Dec; 49(12):529-33. PubMed ID: 23540596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulbar amyotrophic lateral sclerosis: patterns of progression and clinical management.
    Hillel AD; Miller R
    Head Neck; 1989; 11(1):51-9. PubMed ID: 2921111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using phonation time to estimate vital capacity in amyotrophic lateral sclerosis.
    Hillel AD; Yorkston K; Miller RM
    Arch Phys Med Rehabil; 1989 Aug; 70(8):618-20. PubMed ID: 2764692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The symptomatic treatment of amyotrophic lateral sclerosis].
    van den Berg LH; van den Berg JP; Mathus-Vliegen EM; Kampelmacher MJ; van Kesteren RG; Jennekens FG
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):513-8. PubMed ID: 15054949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.